Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_2
1
50%
Ph not_applicable
1
50%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 2Efficacy & side effects
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

2

all time

Status Distribution
Active(2)

Detailed Status

Not yet recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
0
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 21 (50.0%)
N/A1 (50.0%)

Trials by Status

not_yet_recruiting150%
enrolling_by_invitation150%

Recent Activity

0 active trials
Showing 2 of 2
not_yet_recruitingphase_2

Multicenter Phase II Trial of NRICM102 Combined With Standard Therapy in Pneumonia

NCT07583992
enrolling_by_invitationnot_applicable

Evaluation of the Safety and Clinical Efficacy of NRICM102 in Patients With Chronic Lower Respiratory Tract Diseases

NCT06690203

Clinical Trials (2)

Showing 2 of 2 trials
NCT07583992Phase 2

Multicenter Phase II Trial of NRICM102 Combined With Standard Therapy in Pneumonia

Not Yet Recruiting
NCT06690203Not Applicable

Evaluation of the Safety and Clinical Efficacy of NRICM102 in Patients With Chronic Lower Respiratory Tract Diseases

Enrolling By Invitation

All 2 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
2